advertisement
Wan KHN 18
Showing records 1 to 18 | Display all abstracts from Wan KHN98560 Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial
Leung CKS
Trials 2022; 23: 45
98460 Diagnostic assessment of glaucoma and non-glaucomatous optic neuropathies via optical texture analysis of the retinal nerve fibre layer
Leung CKS
Nature biomedical engineering 2022; 6: 593-604
98560 Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial
Ren ST
Trials 2022; 23: 45
98460 Diagnostic assessment of glaucoma and non-glaucomatous optic neuropathies via optical texture analysis of the retinal nerve fibre layer
Lam AKN; Weinreb RN
Nature biomedical engineering 2022; 6: 593-604
98560 Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial
Chan PPM
Trials 2022; 23: 45
98460 Diagnostic assessment of glaucoma and non-glaucomatous optic neuropathies via optical texture analysis of the retinal nerve fibre layer
Garway-Heath DF
Nature biomedical engineering 2022; 6: 593-604
98560 Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial
Wan KHN; Wan KHN
Trials 2022; 23: 45
98460 Diagnostic assessment of glaucoma and non-glaucomatous optic neuropathies via optical texture analysis of the retinal nerve fibre layer
Yu M
Nature biomedical engineering 2022; 6: 593-604
98560 Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial
Kam AKW
Trials 2022; 23: 45
98460 Diagnostic assessment of glaucoma and non-glaucomatous optic neuropathies via optical texture analysis of the retinal nerve fibre layer
Guo PY
Nature biomedical engineering 2022; 6: 593-604
98560 Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial
Lai GWK; Chiu VSM
Trials 2022; 23: 45
98460 Diagnostic assessment of glaucoma and non-glaucomatous optic neuropathies via optical texture analysis of the retinal nerve fibre layer
Chiu VSM; Wan KHN
Nature biomedical engineering 2022; 6: 593-604
98560 Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial
Ko MWL
Trials 2022; 23: 45
98460 Diagnostic assessment of glaucoma and non-glaucomatous optic neuropathies via optical texture analysis of the retinal nerve fibre layer
Wan KHN
Nature biomedical engineering 2022; 6: 593-604
98560 Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial
Ko MWL
Trials 2022; 23: 45
98460 Diagnostic assessment of glaucoma and non-glaucomatous optic neuropathies via optical texture analysis of the retinal nerve fibre layer
Wong M
Nature biomedical engineering 2022; 6: 593-604
98560 Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial
Yiu CKF; Yu MCY
Trials 2022; 23: 45
98460 Diagnostic assessment of glaucoma and non-glaucomatous optic neuropathies via optical texture analysis of the retinal nerve fibre layer
Wu KZ; Cheung CYL; Lin C; Chan CKM; Chan NCY; Kam KW; Lai GWK
Nature biomedical engineering 2022; 6: 593-604